As Varian Medical Systems INC (VAR) Market Valuation Rose, New Amsterdam Partners LLC Trimmed Its Holding

April 19, 2018 - By Dolores Ford

Varian Medical Systems, Inc. (NYSE:VAR) LogoInvestors sentiment decreased to 0.8 in Q4 2017. Its down 0.22, from 1.02 in 2017Q3. It turned negative, as 37 investors sold VAR shares while 194 reduced holdings. 63 funds opened positions while 122 raised stakes. 87.00 million shares or 3.31% less from 89.98 million shares in 2017Q3 were reported. 2,549 are held by Raymond James Tru Na. Lmr Partners Llp reported 0.08% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). Laurion Cap Management LP has invested 0.01% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). Pinnacle Assoc owns 15,137 shares. Welch Forbes Lc holds 18,937 shares or 0.06% of its portfolio. Stifel Fincl has 0.04% invested in Varian Medical Systems, Inc. (NYSE:VAR) for 109,810 shares. Guggenheim Limited Liability Company reported 0.11% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). Gates Cap Mgmt Inc reported 440,418 shares or 1.18% of all its holdings. Jefferies Gp Ltd Co reported 0.06% in Varian Medical Systems, Inc. (NYSE:VAR). Stratos Wealth Prtn reported 1,923 shares. Hussman Strategic Advsrs Inc holds 10,900 shares or 0.35% of its portfolio. Buckingham Asset Ltd Company holds 2,391 shares or 0.06% of its portfolio. Voloridge Inv Mngmt Limited Com stated it has 6,004 shares. Tiverton Asset Mngmt Limited Co holds 0.01% or 1,392 shares in its portfolio. Hm Payson And owns 16,814 shares for 0.08% of their portfolio.

Since October 18, 2017, it had 0 insider buys, and 19 sales for $22.18 million activity. KENNEDY KOLLEEN T sold 3,513 shares worth $425,622. Another trade for 863 shares valued at $93,575 was made by KUO JOHN W on Tuesday, January 16. The insider WILSON DOW R sold 24,000 shares worth $3.04M. The insider BOSTROM SUSAN L sold $235,413. ILLINGWORTH DAVID J had sold 5,651 shares worth $692,560 on Tuesday, March 6. The insider LARET MARK R sold $274,383.

New Amsterdam Partners Llc decreased its stake in Varian Medical Systems Inc (VAR) by 88.19% based on its latest 2017Q4 regulatory filing with the SEC. New Amsterdam Partners Llc sold 41,352 shares as the company’s stock rose 9.85% while stock markets declined. The institutional investor held 5,539 shares of the health care company at the end of 2017Q4, valued at $616,000, down from 46,891 at the end of the previous reported quarter. New Amsterdam Partners Llc who had been investing in Varian Medical Systems Inc for a number of months, seems to be less bullish one the $11.52B market cap company. The stock increased 2.50% or $3.08 during the last trading session, reaching $126.13. About 827,837 shares traded or 12.00% up from the average. Varian Medical Systems, Inc. (NYSE:VAR) has risen 32.94% since April 19, 2017 and is uptrending. It has outperformed by 21.39% the S&P500.

New Amsterdam Partners Llc, which manages about $500.28M US Long portfolio, upped its stake in Potlatch Corp (NASDAQ:PCH) by 63,076 shares to 195,941 shares, valued at $9.78 million in 2017Q4, according to the filing.

Analysts await Varian Medical Systems, Inc. (NYSE:VAR) to report earnings on April, 25 after the close. They expect $1.03 EPS, up 15.73 % or $0.14 from last year’s $0.89 per share. VAR’s profit will be $94.04 million for 30.61 P/E if the $1.03 EPS becomes a reality. After $1.06 actual EPS reported by Varian Medical Systems, Inc. for the previous quarter, Wall Street now forecasts -2.83 % negative EPS growth.

Varian Medical Systems, Inc. (NYSE:VAR) Ratings Coverage

Among 8 analysts covering Varian Medical Systems (NYSE:VAR), 3 have Buy rating, 2 Sell and 3 Hold. Therefore 38% are positive. Varian Medical Systems has $132 highest and $98.0 lowest target. $113.13’s average target is -10.31% below currents $126.13 stock price. Varian Medical Systems had 11 analyst reports since October 25, 2017 according to SRatingsIntel. Goldman Sachs downgraded the stock to “Sell” rating in Thursday, January 25 report. The rating was maintained by JP Morgan on Thursday, January 25 with “Neutral”. The rating was maintained by Citigroup on Thursday, January 25 with “Buy”. The firm has “Hold” rating by Robert W. Baird given on Thursday, January 25. On Thursday, October 26 the stock rating was maintained by Robert W. Baird with “Hold”. RBC Capital Markets maintained the shares of VAR in report on Thursday, November 30 with “Hold” rating. The firm has “Buy” rating given on Wednesday, October 25 by Jefferies. Barrington upgraded it to “Buy” rating and $130.0 target in Thursday, January 25 report. The rating was maintained by Citigroup on Monday, October 30 with “Neutral”. The rating was maintained by RBC Capital Markets on Thursday, January 25 with “Hold”.

Varian Medical Systems, Inc. (NYSE:VAR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.